Double immune reconstitution therapy: Cladribine after alemtuzumab in the treatment of multiple sclerosis.
Ivan AdamecIvan JovanovićMagdalena Krbot SkorićMario HabekPublished in: European journal of neurology (2021)
This report provides a framework for treating people with MS with sequential immune reconstitution therapies.